Fibroblast Growth Factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) study

Danilo Fliser, Barbara Kollerits, Ulrich Neyer, Donna P. Ankerst, Karl Lhotta, Arno Lingenhel, Eberhard Ritz, Florian Kronenberg

Research output: Contribution to journalArticlepeer-review

535 Scopus citations

Fingerprint Dive into the research topics of 'Fibroblast Growth Factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) study'. Together they form a unique fingerprint.

Medicine & Life Sciences